Viewing Study NCT00980603


Ignite Creation Date: 2025-12-24 @ 7:34 PM
Ignite Modification Date: 2026-01-01 @ 9:38 PM
Study NCT ID: NCT00980603
Status: UNKNOWN
Last Update Posted: 2009-09-21
First Post: 2009-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
Sponsor: National Cancer Center, Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module